Zinger Key Points
- Affirm announced a partnership with Coast Dental to enhance payments for dental services.
- Coast Dental has nearly 100 locations across Florida, Georgia and Texas where these payment options are available.
- Brand New Membership Level: Benzinga Trade Alerts
Affirm Holdings, Inc. AFRM stock is trading higher on Monday after the company announced a partnership with Coast Dental to enhance payments for dental services.
What To Know: The partnership allows approved Coast Dental patients to use Affirm’s payment options for general and specialty dental services, including exams, cleanings and veneers. Coast Dental has nearly 100 locations across Florida, Georgia and Texas where these payment options are available.
The partnership allows patients at these locations to complete a quick eligibility check by scanning a QR code with their smartphone. If approved, they can select from biweekly or monthly payment plans to finalize their purchase.
“Patients deserve flexible, reliable payment options to get the care they need, whether it’s for a routine cleaning, an urgent procedure or a cosmetic enhancement,” said Yvonne Herrera, Vice President of SMB and Platform Partnerships at Affirm.
“Through our partnership with Coast Dental, we’re making it easier than ever for approved patients to manage their dental care costs with simple, transparent payment options—no hidden fees, just the flexibility to pay over time and make their money go further responsibly.”
This partnership announcement comes as Affirm grows its presence in healthcare, increasing its network of active healthcare providers by 90% year-over-year. Coast Dental is now part of this network, joining providers like GoodRx, RepeatMD and Veterinary Emergency Group.
Affirm, last week, reported earnings for the 2025 fiscal year second quarter. The company reported earnings per share of 23 cents, beating analysts' estimate of a loss of 16 cents per share. In addition, Affirm reported sales of $866.38 million, beating analysts' estimate of $807.16 million.
Analyst Changes: Following its recent earnings report, multiple analysts continue to issue price target adjustments.
- Barclays analyst Ramsey El-Assal maintained an Overweight rating on Affirm and raised the price target from $75 to $85.
- Goldman Sachs analyst Will Nance maintained a Buy rating on Affirm and raised the price target from $78 to $90.
See Also: China Sets Sights On Apple, Nvidia And Other US Tech Companies As Trade Tensions Rise
AFRM Price Action: At the time of publication, Affirm stock is trading 2.61% higher at $77.18, according to data from Benzinga Pro.
Image: via Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.